Medicament for treating acute and chronic leukemia and preparation method thereof

Abstract

The invention discloses a medicament for treating acute and chronic leukemia. The medicament comprises the active components of indigo naturalis, American ginseng, honeycomb, pseudo-ginseng, artificial bezoar, realgar and accessories. The indigo naturalis, honeycomb, realgar and artificial bezoar in the medicament has the function of heat clearing and detoxifying, and realgar can eliminate dampness and reduce phlegm; pseudo-ginseng has the function of scattering blood stasis and stopping bleeding and producing blood; American ginseng can tonify Qi, nourish the spleen, generate qi and blood, nourish yin, clear heat, moisturize dryness and generate body fluid. Combination of the various drugs plays the effects of clearing heat, detoxifying, supplementing Qi, nourishing Yin, removing blood stasis and stopping bleeding. The prescription provided by the invention concisely uses the drugs to reach subtle compatibility; the medicament can effectively kill leukemia cells, improve the clinical efficiency, rapidly treat clinical symptoms of anemia, fever, hemorrhage, hepatosplenomegaly and joint pain occurred in period of disease of leukemia, effectively promote the recovery of normal hematopoietic function of the patients, can also be combined with radiotherapy and chemotherapy in the treatment of leukemia, significantly improve the treatment effect of chemotherapy drug, reduce the side effects of chemotherapy drugs and enhance the life quality of the patients.

Description

technical field [0001] The invention belongs to the technical field of preparation of Chinese patent medicines, in particular to a medicine for treating various types of acute and chronic leukemia and a preparation method thereof. Background technique [0002] Leukemia is a malignant disease of hematopoietic tissue, also known as "blood cancer". It is characterized by the unlimited proliferation of a large number of leukemia cells in the bone marrow and other hematopoietic tissues, and enters the peripheral blood, while the production of normal blood cells is significantly inhibited. This disease ranks first among malignant diseases in young people. The etiology of leukemia is still not completely clear. Viruses may be the main pathogenic factor, but there are many factors such as radiation, chemical poisons (benzene, etc.) or drugs, genetic qualities, etc. may be the cofactors of the disease. According to the degree of immaturity of leukemia cells and the natural course of...

AI Technical Summary

Problems solved by technology

[0003] Leukemia is complex, difficult to treat, and poor prognosis

At present, the common treatment methods are radiotherapy and chemotherapy and bone marrow transplantation, etc., but the side effects of radiotherapy and chemotherapy are very large, destroying the immune function of the human body and the ability to resist leukemia, especially while killing leukemia cells, it also seriously damages the normal bone marrow cell system , so that chemotherapy can not continue, severe bleeding, infection loss of treatment, leading to the death of the patient; bone marrow transplantation due to the difficulty of bone marrow source, matching only accounts for 1 / 4 of immediate family members, the success rate is only 30-40%. There are many complications, and the recurrence rate is as high as 70% within 5 years, which aggravates the suffering of patients, and is expensive, which also brings serious economic burden to patients and the government.

Images